Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The transaction is expected to close in the first quarter of 2022
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
Subscribe To Our Newsletter & Stay Updated
